[The anti-tumor effect of several mono- and di-chlor-sym.triazine derivatives].
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D005260:Female; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000188:drug therapy; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy*; D012513:Sarcoma, Experimental / Q000473:pathology; D013852:Thiotepa / Q000009:adverse effects / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use*
D014227:Triazines; D013852:Thiotepa; D008558:Melphalan
O protivoopukholevom deĭstvii nekotorykh proizvodnykh mono- i dikhlor-simm.triazina.